AIRLINK 175.89 Decreased By ▼ -0.93 (-0.53%)
BOP 10.98 Decreased By ▼ -0.11 (-0.99%)
CNERGY 8.00 Increased By ▲ 0.06 (0.76%)
FCCL 46.12 Increased By ▲ 1.18 (2.63%)
FFL 16.07 Decreased By ▼ -0.04 (-0.25%)
FLYNG 27.42 Decreased By ▼ -0.86 (-3.04%)
HUBC 143.96 Increased By ▲ 2.18 (1.54%)
HUMNL 13.35 Increased By ▲ 0.10 (0.75%)
KEL 4.50 Increased By ▲ 0.07 (1.58%)
KOSM 5.98 Decreased By ▼ -0.05 (-0.83%)
MLCF 59.50 Increased By ▲ 1.05 (1.8%)
OGDC 232.75 Increased By ▲ 8.56 (3.82%)
PACE 5.88 Decreased By ▼ -0.05 (-0.84%)
PAEL 47.48 Increased By ▲ 1.58 (3.44%)
PIAHCLA 17.97 Decreased By ▼ -0.19 (-1.05%)
PIBTL 10.58 Decreased By ▼ -0.02 (-0.19%)
POWER 11.38 Increased By ▲ 0.08 (0.71%)
PPL 193.30 Increased By ▲ 7.82 (4.22%)
PRL 37.00 Increased By ▲ 0.09 (0.24%)
PTC 23.77 Increased By ▲ 0.08 (0.34%)
SEARL 99.87 Increased By ▲ 1.47 (1.49%)
SILK 1.15 No Change ▼ 0.00 (0%)
SSGC 37.19 Decreased By ▼ -0.19 (-0.51%)
SYM 14.95 Decreased By ▼ -0.06 (-0.4%)
TELE 7.75 Decreased By ▼ -0.07 (-0.9%)
TPLP 10.87 Decreased By ▼ -0.09 (-0.82%)
TRG 65.14 Decreased By ▼ -1.00 (-1.51%)
WAVESAPP 10.91 Increased By ▲ 0.03 (0.28%)
WTL 1.34 No Change ▼ 0.00 (0%)
YOUW 3.81 No Change ▼ 0.00 (0%)
BR100 12,609 Increased By 173.5 (1.4%)
BR30 39,262 Increased By 678.1 (1.76%)
KSE100 117,772 Increased By 1139.1 (0.98%)
KSE30 36,296 Increased By 474.7 (1.33%)

Pfizer Inc

Indian shares rise
Markets

Indian shares rise

BENGALURU: Indian shares ended higher on Monday, led by financial and energy stocks, while Pfizer Inc’s local arm...
Published 09 Nov, 2021 04:48am
Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion
Business & Finance

Pfizer lifts sales forecast for COVID-19 vaccine to $26 billion

  • It is expected to make up for more than one-third of Pfizer's full-year sales, with the company in supply talks with several countries for 2022 and beyond.
  • "Based on what we've seen, we believe that a durable demand for our COVID-19 vaccine - similar to that of the flu vaccines - is a likely outcome," Chief Executive Albert Bourla said in his prepared remarks.
Published 04 May, 2021 07:48pm
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Published 30 Apr, 2021 04:51pm